Industry Reports
Stable consolidated revenues, costs and losses for Hybrigenics
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on research and development of new treatments against proliferative...
Industry Reports
Hikma Pharma Q1 revenue rises
Hikma Pharmaceuticals, a manufacturer of a range of both branded and non-branded generic and inlicensed products, reported revenue of $394.76m for the first quarter...
Industry Reports
Furiex Pharmaceuticals Enters into Loan Agreement for up to $15 Million Furiex Pharmaceuticals Inc.
Furiex Pharmaceuticals, Inc. announced it has entered into a loan agreement with MidCap Financial and Silicon Valley Bank to provide up to $15.0 million...
Industry Reports
China Shenghuo Q2 sales climb 58%
China Shenghuo, engaged in the research, development, manufacture and marketing of Sanchi-based medicinal and pharmaceutical, nutritional supplement and cosmetic products, has reported sales of...
Industry Reports
Vivus reports Qnexa phase 3 study results
Vivus, a developer of therapies to address obesity, sleep apnea, diabetes and male sexual health, has reported the data of Qnexa in its Phase...
Industry Reports
Novartis delivers strong financial results and four major approvals
Novartis' net sales rose 27% (+19% cc) to USD 14.9 billion. Currency benefited sales by 8% as the US dollar weakened against most currencies....
Industry Reports
Echo Therapeutics Announces First Quarter 2011 Financial Results
Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read